Metraipolis › archive › dc_f95d904a4fa0

Public perceptions and support for introduced microbes to combat hospital-acquired infections and antimicrobial resistance — Europe PMC PMID:41061000

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41061000
DOI
10.1371/journal.pone.0332578
License (as archived)
CC0-1.0
Archived
2026-10-08T00:14:27.605Z
SHA-256 of the archived text
94880106e5a0df24bcb05d5389315a10871b0befd40d81b0ab0d13525099bd42
Stable URL of this page
https://metraipolis.com/documento/dc_f95d904a4fa0

How to cite

Public perceptions and support for introduced microbes to combat hospital-acquired infections and antimicrobial resistance — Europe PMC PMID:41061000 — Europe PMC (en), https://europepmc.org/article/MED/41061000 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_f95d904a4fa0 (Metraipolis archive dc_f95d904a4fa0, sha256 94880106e5a0df24bcb05d5389315a10871b0befd40d81b0ab0d13525099bd42)
BibTeX
@misc{dcf95d904a4fa0,
  title = {Public perceptions and support for introduced microbes to combat hospital-acquired infections and antimicrobial resistance — Europe PMC PMID:41061000},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41061000},
  note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_f95d904a4fa0; sha256 94880106e5a0df24bcb05d5389315a10871b0befd40d81b0ab0d13525099bd42},
  year = {2026}
}

Archived text

Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/41061000. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

Hospital-acquired infections and antimicrobial resistance (AMR) remain major global health threats, prompting interest in microbiome-based interventions that introduce beneficial microbes or genetic interventions to control pathogens and reduce AMR genes in hospital environments. Microbiome engineering, which can use advanced biotechnology, genetics, and microbial ecology principles to restructure microbial communities, is a rapidly growing field with applications in infection control. As researchers explore deploying beneficial microbes and other genetic interventions in clinical settings like hospital sinks, public perception becomes critical to responsible implementation. This study addresses how U.S. adults perceive microbiome evaluation, and education. Drawing on a nationally representative survey (N = 1,000), we conducted hierarchical ordinary least squares regression modeling to assess predictors of support across three domains: implementation of introduced microbiomes (IM), rigorous testing, and education for healthcare stakeholders. Results demonstrate that support for IM in hospital sinks is shaped less by demographic traits and more by emotional responses, trust in institutional efficacy, belief in intervention benefits, and a desire to learn about microbiome science. These findings advance previous knowledge by distinguishing cognitive, affective, and contextual predictors across distinct types of support. Contrary to expectations, prior familiarity and information-seeking were negatively associated with IM support, suggesting that some engagement or exposure to risk-framing may drive skepticism. Meanwhile, emotional reactions and perceived efficacy consistently predicted support for IM, testing, and education (i.e., across all dependent variables), underscoring the need to address affective and trust-based components of public engagement. This research contributes to an emerging empirical foundation for responsible microbiome innovation by grounding the analysis in the Responsible Research and Innovation (RRI) framework. With the technology still in early development, these insights provide critical guidance for biotechnology developers, policymakers, and hospital leaders seeking to align microbiome engineering with societal values through transparent communication, rigorous oversight, and inclusive education.

Tema degli esploratori: finanziamenti e grant (ricerca Europe PMC «research funding», solo open access).
Pubblicazione: PloS one, 2025 (prima pubblicazione 2025-10-08).
Identificativi: PMID 41061000 · PMCID PMC12507289 · DOI 10.1371/journal.pone.0332578.
Descrittori MeSH principali: Cross Infection; Drug Resistance, Microbial; Public Opinion; Microbiota.
Pagina: https://europepmc.org/article/MED/41061000 — https://doi.org/10.1371/journal.pone.0332578. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito).
Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0.
Letto il 2026-10-07T23:46:04.744Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.